Green light for new medicines
by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.
by Gary Finnegan: The European Medicines Agency’s influential Committee for Medicinal Products for Human Use (CHMP) has given the green light for ten new medicines, as well as offering… read more.
John Ultmann Memorial Lecture / by Maria Dalby. Cutaneous lymphomas are rare conditions that require careful linking of clinical features with pathological findings for accurate diagnoses and effective… read more.
Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby. Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) demonstrated the value of a new interactive iPad app that helps… read more.
Daily bathing of pediatric patients with disposable cloths containing 2 percent chlorhexidine gluconate (CHG) reduced central line-associated bloodstream infections (CLABSIs) by 59 percent and saved approximately $300,000 in… read more.
A technique to increase the flow of blood from the umbilical cord into the infant’s circulatory system improves blood pressure and red blood cell levels in preterm infants… read more.
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer’s disease.
by Bruce Sylvester: Menopausal women having difficulty with time management, attention, organization, memory, and problem solving (also known as “executive functions”) appear to benefit from treatment with lisdexamfetamine,… read more.
by Bruce Sylvester: Rociletinib, an investigative therapy for treatment resistant EGFR-mutation driven lung tumors, shows activity against the most common resistance mutation, and it significantly improves clinical outcomes.
by Gary Finnegan: A new study has revealed a number of factors that appear to predict a child’s risk of developing ankylosing spondylitis (AS).
by Gary Finnegan: People with terminal cancer often require palliative care in the late stages of their lives. This branch of medicine has long been lauded for the… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.